Add BrightSurf on Google Email

Johns Hopkins Medicine


‘Sting’ protein’s efforts to clean up brain cell damage may speed Parkinson’s disease progress

A Johns Hopkins Medicine study found that a protein called STING responds to clean-up signals in brain cells damaged by Parkinson’s disease by creating a cycle of inflammation that accelerates the disease’s progression. In mice with deactivated STING proteins, there was less microglial activity and brain cell death.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateMay 19, 2022

Preliminary study shows minimally invasive diagnostic biomarker strategy successful in detecting early esophageal cancer

A minimally invasive device combined with molecular biomarkers has shown a 90% success rate in detecting esophageal squamous cell carcinoma, the predominant subtype of esophageal cancer. Early detection is crucial to improve survival rates, as symptoms often become apparent too late for effective treatment.

SourceJohns Hopkins Medicine·JournalGastroenterology·DateMay 18, 2022

Lab grown, self-sustainable muscle cells repair muscle injury and disease, mouse study shows

Scientists at Johns Hopkins Medicine have successfully cultivated human muscle stem cells capable of renewing themselves and repairing muscle tissue damage in mice. The self-renewing stem cells were created by reprogramming laboratory-grown human skin cells, which then differentiated into specific cell types using a nutrient-rich broth.

SourceJohns Hopkins Medicine·JournalCell Stem Cell·DateApr 20, 2022

Study: Mediterranean-style diet further linked to reduced risk of preeclampsia in pregnant women of all races

A new study found that following a Mediterranean-style diet can lower the risk of preeclampsia by at least 20% in pregnant women. The research surveyed over 8,000 women and found that racial differences in rates of preeclampsia were more related to socioeconomic factors than genetic or biological ones.

SourceJohns Hopkins Medicine·JournalJournal of the American Heart Association·DateApr 20, 2022

Immunotherapy plus chemotherapy before surgery improves outcomes for lung cancer patients

Adding immunotherapy to chemotherapy before surgery reduced the risk of recurrence and death in lung cancer patients by 37%, according to a phase III trial. The treatment also led to a nearly twelvefold increase in pathological complete response, with 24% of patients achieving no active cancer remaining when the tumor was removed.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateApr 11, 2022

New Johns Hopkins study explores relationship between psychedelics and consciousness

A new Johns Hopkins study examines the link between psychedelics and consciousness, revealing a significant increase in attributing consciousness to various entities following a psychedelic experience. The study found that participants who reported belief-changing experiences showed substantial increases in attributing consciousness to...

SourceJohns Hopkins Medicine·JournalFrontiers in Psychology·DateMar 31, 2022

FDA approved new immunotherapy regimen for patients with melanoma based on Johns Hopkins Research

The FDA has approved a novel combination therapy of relatlimab and nivolumab for patients with metastatic or inoperable melanoma. The treatment significantly delayed cancer progression time compared to nivolumab alone. LAG-3 blockade reinvigorated T cell anti-tumor activity, establishing the pathway as the third immune checkpoint target.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateMar 23, 2022

Making the invisible visible: A clearer ‘picture’ of blood vessels in health and disease thanks to new imaging approach

Researchers developed a new imaging approach called VascuViz to visualize blood vessels at different spatial scales. The method enables detailed mathematical models and complementary images to clarify the role of blood flow in health and disease, advancing our understanding of tissues throughout the body.

SourceJohns Hopkins Medicine·JournalNature Methods·DateFeb 28, 2022

Patient safety program reduces unnecessary antibiotic use in long-term care facilities

A study published in JAMA Network Open shows that a comprehensive system to improve antibiotic stewardship in long-term care facilities significantly reduces the use of antibiotics, leading to better patient outcomes and reduced drug-resistant bacterial strains. The program empowered clinicians to make informed decisions about prescrib...

SourceJohns Hopkins Medicine·JournalJAMA Network Open·DateFeb 28, 2022

SARS-CoV-2 protein targeted by immune cells also triggers response in bat Coronaviruses

Researchers at Johns Hopkins Medicine discovered a peptide on the SARS-CoV-2 spike protein that triggers an immune response in humans and is also recognized by cells of the immune system, suggesting potential for protection against future zoonotic outbreaks. The study supports the development of multivalent vaccines against a broad spe...

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateFeb 16, 2022

Psilocybin treatment for major depression effective for up to a year for most patients, study shows

A study by Johns Hopkins Medicine researchers found that psilocybin-assisted therapy can lead to significant and durable improvements in depression, with effects lasting at least a year for most patients. The treatment was shown to produce large decreases in depression severity and stable rates of response throughout the follow-up period.

SourceJohns Hopkins Medicine·JournalJournal of Psychopharmacology·DateFeb 15, 2022

Special testing of kidney tissue from deceased COVID-19 donor documents safe transplantation of the organ, Johns Hopkins researchers report

Researchers at Johns Hopkins Medicine have successfully transplanted a kidney from a COVID-19 donor, demonstrating that healthy kidneys from such donors can be safely transplanted. The recipient has shown no signs or symptoms of the virus and has excellent kidney function since the transplant.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Transplantation·DateJan 31, 2022

Young sexual minority men and transgender women are at higher risk of transactional sex

A recent survey by Johns Hopkins Medicine researchers found that about 22% of young sexual minority males and transgender females engage in transactional sex. The practice is associated with HIV exposure, substance use disorder, and unstable housing. Researchers plan to develop interventions to address economic and social vulnerabilities.

SourceJohns Hopkins Medicine·JournalJournal of Adolescent Health·DateJan 25, 2022

Large field hospital study shows rapid Covid-19 test compares solidly with PCR detection

A large field hospital study shows that a rapid Covid-19 test is as accurate as PCR detection, with high sensitivity rates for both symptomatic and asymptomatic patients. The rapid antigen test's ease of use, time savings, and cost effectiveness make it an ideal solution to reduce testing disparities in medically underserved communities.

SourceJohns Hopkins Medicine·JournalMicrobiology Spectrum·DateDec 7, 2021

Mouse study suggests manipulation of certain nerve cells can help regenerate lost heart muscle

Researchers at Johns Hopkins Medicine have discovered that manipulating certain nerve cells may trigger the formation of new heart muscle cells, restoring heart function after heart attacks. The study found that removing specific genes associated with circadian rhythms increased neonatal heart size and cardiomyocyte numbers by up to 10%.

SourceJohns Hopkins Medicine·JournalScience Advances·DateDec 2, 2021

Simultaneous repair of heart valves may benefit some adults

A two-year follow-up of participants found that those who had both their mitral valve and tricuspid valve repaired at the same time experienced better outcomes, including less progression to moderate or severe leakage. This study provides high-level evidence for surgeons on how to perform tricuspid valve repair in these patients.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateNov 16, 2021

Study shows immune cells against COVID-19 stay high in number six months after vaccination

Researchers found that CD4+ T lymphocytes — immune system cells — produced by people who received COVID-19 vaccines persisted at high levels six months after vaccination, with a significant response against the delta variant. The study also showed that vaccine-elicited fighters recognize and help attack coronavirus delta variant.

SourceJohns Hopkins Medicine·JournalClinical Infectious Diseases·DateNov 16, 2021